drugset / Trial / NCT00351533
A Phase II Randomized Trial of Fish Oil in Patients With Acute Lung Injury (ALI)
Phase 2
Completed
90 enrolled
University of Washington
Acute Respiratory Distress Syndrome Foundation · collabAmerican Society for Parenteral and Enteral Nutrition · collabAmerican Thoracic Society · collabNational Heart, Lung, and Blood Institute (NHLBI) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether fish oil (containing omega-3 fatty acids) given enterally is safe and effective in reducing lung and systemic inflammation seen in acute lung injury.
Timeline
- Start
- 2006-07
- Primary completion
- 2009-01
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fish oil | Other / unclassified | 7.5 ml | Other |